Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumors contained specific clusters of B cells, according to new research published in Nature.
Immunotherapy strengthens the immune system so that it can fight cancer more effectively. One type of immunotherapy is checkpoint therapy, that targets the checkpoints that exist to prevent the immune system from becoming too active. However, releasing these brakes on the immune system is necessary to fight certain types of cancer, something that can be done with antibodies.
But far from all patients are being helped by the treatment, and intensive research is underway to understand who benefits the most from checkpoint therapy, and how it can be made even more effective. A great deal of focus so far has been on the immune cells called T cells.
The new study sheds light on the role of another immune cell in immunotherapy: B cells. Researchers have shown that clusters of B cells in melanoma tumors, so-called tertiary lymphoid structures, are linked to the prognosis.
"By studying tissue samples from 177 melanoma patients, we have been able to see that when these B-cell structures were present in the tumor, the patient had a better prognosis and responded better to immunotherapy", says the senior author of the study.
It has previously been known that these structures are sometimes found in tumors, but it is only now that they have been linked to prognosis and treatment response. In the same issue, Nature has published two other research articles that involve the same B-cell structures, albeit in other tumors - soft tissue sarcoma and kidney cancer - where there was also an association with improved response to immunotherapy.
The results of the study confirm that it is not only the T-cells that are important, but that the B-cells also play a role in the immune response against cancer cells.
"Now we want to continue with prospective studies and investigate whether it is possible to stimulate the immune system to form these structures in tumors, and thus improve the effect of immunotherapy", concludes another author.
https://www.nature.com/articles/s41586-019-1914-8
https://www.nature.com/articles/s41586-019-1906-8
https://www.nature.com/articles/s41586-019-1922-8
B cells and tertiary lymphoid structures (TLS) linked to effective cancer immunotherapy
- 5,023 views
- Added
Edited
Latest News
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Other Top Stories
Another gene that causes MND with defective mitochondria and lipid…
Read more
Insects harbor over a thousand genes from microbes, which help them…
Read more
New dementia risk genes identified!
Read more
Glycoprotein GPNMB is a possible biomarker for Parkinson's Disease…
Read more
How a gene variant protects against Alzheimer's disease
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Selenium, diabetes, and the…
By newseditor
Posted 23 Apr
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar